A 17-year-old previously healthy female developed generalized tonic-clonic seizures refractory to first line treatments. She was quickly escalated to pentobarbital. MRI showed increased T2 signal and restricted diffusion in the left hippocampus. CSF studies revealed mild pleocytosis and elevated protein. High dose steroids and anakinra were initiated on day 2 of hospitalization (DOH 2) and plasma exchange on DOH 3. Cytokine panel revealed elevated IL-6 in CSF and tocilizumab was administered on DOH 15.
She was weaned off Phenobarbital on DOH 31 after treatment with seven anti-seizure medications, ketogenic diet, and VNS placement on DOH 26. She was finally discharged on DOH 114 able to abulate with assistance and had somme cognitive deficits. Steroids and anakinra were discontinued 1-2 months after discharge.
One month later, she presented with lethargy. CSF indices were similar to prior and IgG index was elevated. EEG showed no electrographic seizure activity. MRI brain revealed foci of nodular and linear leptomeningeal enhancement within both cerebral hemispheres. Brain biopsy demonstrated vasculitis. She was started on cyclophosphamide and began to improve clinically.